Ingrid Gafanhão

Ingrid Gafanhão is a senior Equity Research Analyst with six years of experience in providing investment ideas to institutional investors. Ingrid specializes in healthcare and is responsible for closely following key European biotechs leading innovation in the cell and gene therapy spaces. Working for key European investment banks that focus on small/mid-sized companies, Ingrid developed an extensive understanding of the factors that drive value in healthcare companies. Ingrid has a bachelor’s degree in biology from Universidad Estadual de Campinas (Brazil) and a master’s degree in Science-Based Business from Leiden University (The Netherlands).